Löwenstein Medical provides an insight into the latest innovation developed to protect the lungs of the tiniest and most vulnerable patients.
Since Löwenstein Medical was founded in 1986, the company has been focused on the field of neonatology and has gained a reputation for pioneering advances in medical ventilation and thermal therapy systems for pre-term and neonates.
The ventilation of pre-term and neonates is an especially challenging discipline within intensive care medicine. The lungs of pre-term babies are not yet fully developed. The alveoli (air sacs) are smaller and fewer in number, resulting in increased airway resistance and reduced lung compliance (lung elasticity).
Immature lungs are extremely sensitive to volutrauma (damage caused by excessive tidal volumes), barotrauma (damage caused by excessive airway pressures) and atelectrauma (damage caused by the repeated collapse and reinflation of the alveoli). This can lead to the development of a chronic lung disease, bronchopulmonary dysplasia (BPD), and to associated long-term damage.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.